Millie
your market intelligence analyst
Search Results
34,222 results
Your search is now limited to «Cancer News» expert search.
Orissa POST (India) 04/02/2020 10:09
My daughter said because I am under cancer remission so I am at a big risk so she told me to come to Goa.
More from Orissa POST (India):
Onclive 04/02/2020 10:09
Pembrolizumab significantly improved progression-free survival versus chemotherapy in patients with microsatellite instability-high or mismatch repair deficient unresectable or metastatic colorectal cancer.
More from Onclive:
Jerusalem Post (Israel) 04/02/2020 09:50
Seeking to ensure that the most vulnerable receive necessary medical treatment, the Inbar and Marius Nacht Family Foundation has partnered with breast cancer emergency relief organization Israel Lemonade Fund to establish a network of national transportation services for cancer patients unable to travel to appointments.
More from Jerusalem Post (Israel):
ClinicalTrials.gov 04/02/2020 09:34
Condition : Triple Negative Breast Cancer Interventions : Drug: Paclitaxel; Drug: Carboplatin; Biological: Nivolumab; Biological: Cabiralizumab; Procedure: Tumor biopsy; Procedure: Bone marrow; Procedure: Blood draw Sponsors : Washington University School of Medicine; Bristol-Myers Squibb Not yet recruiting.
More from ClinicalTrials.gov:
The Environmental Protection Agency (EPA) has determined that asbestos poses an unreasonable risk of cancer to both workers and consumers who inhale it, ramping up pressure on the agency to ban the substance.
More from Society of Environmental Journalists:
PhysOrg.com 04/02/2020 09:20
A 3-D-printed brain could make it easier to find cancer treatments.
More from PhysOrg.com:
Now scientists at Yale and collaborators in Greece have found that some unprepossessing neighbors of those stem cells actually harbor a molecular villain that can jump-start cancers of the colon, they report in the journal Nature.
More from Medical Xpress - Medical Research News:
Xconomy 04/02/2020 09:01
Celularity, a New Jersey company developing experimental cancer treatments derived from human placentas, has received the FDA’s blessing to kick off human testing of its lead immunotherapy for cases of COVID-19 disease.
More from Xconomy:
GlobeNewswire 04/02/2020 09:00
TEL AVIV, Israel, April 02, 2020 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) today announced that following the positive interim analysis in the OVAL study, its Japanese licensee NanoCarrier Co., Ltd. (TSE Mothers: 4571), intends to extend the ongoing global Phase 3 OVAL clinical trial in ovarian cancer to patients in Japan.
More from GlobeNewswire:
Business Wire 04/02/2020 08:00
The EV-302 trial is evaluating the combination of PADCEV and pembrolizumab with or without chemotherapy versus chemotherapy alone in patients with previously untreated locally advanced or metastatic urothelial cancer.
More from Business Wire:
Benzinga 04/02/2020 08:00
Mateon/Oncotelic is seeking to leverage its deep expertise in oncology drug development to improve treatment outcomes and survival of cancer patients with a special emphasis on pediatric cancer patients.
More from Benzinga:
FeedNavigator (EU) 04/02/2020 07:56
T2D postmenopausal women have an ~20% increased chance of developing breast cancer, and women with T2D and breast cancer have a 50% increase in mortality compared to breast cancer patients without diabetes.
More from FeedNavigator (EU):
PMLiVE 04/02/2020 07:54
Recommendations from several medical societies include voluntary holds on recruitment of new patients in oncology trials for the time being, due to patient safety concerns,” it added.
More from PMLiVE:
BeiGene doses first patient in phase 1b/2 trial of ZW25 in HER2-positive breast cancer and GEA.
More from Pharmaceutical Business Review:
Grants.gov 04/02/2020 07:15
The award is intended to support the genomic and/or transcriptomic and/or proteomic analysis of currently available clinical specimens with a focus on answering biologic and pathophysiologic questions of clinical relevance in ovarian cancer.
More from Grants.gov:
Genetic Literacy Project 04/02/2020 07:10
CHD and MAM claim the state’s proposal could do “irreparable harm to our children” by exposing them to dangerous radiation and increasing their cancer risk.
More from Genetic Literacy Project:
Send2Press Newswire 04/02/2020 06:00
Importantly, selective toxicity of ROK-001 on cancer cells rather than non-neoplastic (healthy) cell lines account for its' high therapeutic index, while safety profile evaluations confirm that the compound exerts no genotoxicity nor cardiotoxicity.
More from Send2Press Newswire:
Innovent Biologics, the first company whose immunology-based PD-1 anti-cancer drug is covered by China’s national health insurance scheme, has joined the race to find a cure for the coronavirus epidemic sweeping the globe, according to its chairman.The company, based in Suzhou, Jiangsu province, is working to identify antibodies that could potentially "neutralise" the deadly virus, by studying antibodies drawn from people who have recovered from the virus that causes the Covid-19 respiratory...
More from South China Morning Post (China):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications